-$101M
Value of Insider Transactions in the last 2 years

Sign up to access historical data

Sign up

Insider Transactions

Name Transaction Date Sold / Bought Shares Price Value
RIGGS RORY BJan 4, 2024Sell35,702$27.5476$980,000
RIGGS RORY BJan 3, 2024Sell199,098$27.7867$5.5M
RIGGS RORY BJan 2, 2024Sell235,200$28.5165$6.7M
Giuliani Mario GermanoDec 29, 2023Sell65,803$28.0444$1.8M
Giuliani Mario GermanoDec 28, 2023Sell209,863$28.2038$5.9M
Giuliani Mario GermanoDec 27, 2023Sell41,729$28.0082$1.2M
Giuliani Mario GermanoDec 15, 2023Sell10,229$28.0085$290,000
Giuliani Mario GermanoDec 14, 2023Sell364,441$28.9053$11M
Giuliani Mario GermanoDec 13, 2023Sell307,935$28.9542$8.9M
Coyne Terrance P.Aug 10, 2023Sell37,500$30.7491$1.2M
Coyne Terrance P.Jul 13, 2023Sell37,500$30.9322$1.2M
Legorreta Pablo G.Jun 28, 2023Buy130,000$29.5136$3.8M
Legorreta Pablo G.Jun 13, 2023Buy45,000$32.7756$1.5M
Lloyd George W.Jun 6, 2023Sell79,099$33.8158$2.7M
Lloyd George W.Jun 5, 2023Sell19,215$33.5387$640,000
Lloyd George W.Jun 2, 2023Sell92,221$33.6453$3.1M
Lloyd George W.Jun 2, 2023Sell1,686$33.5362$57,000
Legorreta Pablo G.May 24, 2023Buy150,000$32.2496$4.8M
RIGGS RORY BMay 22, 2023Sell1,750,000$32.82$57M
Legorreta Pablo G.May 17, 2023Buy69,612$32.9411$2.3M
Legorreta Pablo G.May 16, 2023Buy160,388$33.5669$5.4M
RIGGS RORY BMar 30, 2023Sell130,024$36.2575$4.7M
Lloyd George W.Mar 29, 2023Sell12,779$37.0268$470,000
RIGGS RORY BMar 29, 2023Sell9,926$36.95$370,000
Lloyd George W.Mar 28, 2023Sell100,000$37.0613$3.7M
Lloyd George W.Feb 23, 2023Sell25,000$37.2663$930,000
Urist MarshallFeb 22, 2023Sell23,333$37.2965$870,000

What's the latest insider transaction for Royalty Pharma?

The most recent insider transaction for Royalty Pharma was conducted by RIGGS RORY B, who sold 35,702 shares on January 4, 2024 at a price of $27.55 per share.

Which insider bought the most RPRX stock over the last two years?

Legorreta Pablo G. has bought the most RPRX stock in the last 2 years, with a total value of $18M.

Which insider has sold the most RPRX stock over the last two years?

RIGGS RORY B has sold the most RPRX stock in the last 2 years, with a total value of $76M.

What is the total value of insider transactions for Royalty Pharma (RPRX) in the last 2 years?

The total value of insider transactions for Royalty Pharma in the last 2 years is negative, amounting to -$101M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.

How do insider transactions over the last 2 years reflect on Royalty Pharma's market confidence?

Over the last 2 years, insider transactions for Royalty Pharma have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.

Why is monitoring insider trading activity important for investors?

Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.